REYON Pharmaceutical Co., Ltd.
KSE 102460.KS
REYON Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -2.10 M
-
REYON Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -3.60 M, a -24.33% change year over year.
-
REYON Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -2.90 M, a 45.40% change year over year.
-
REYON Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -5.31 M, a 25.45% change year over year.
-
REYON Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -7.12 M, a -35.77% change year over year.
| Date | Dividends Paid | Capital Expenditure | Other Financing Activities | Net Cash Used Provided By Financing Activities |
|---|
Don’t Miss A Beat
| CEO | Ms. Soon-Ock Jung |
| IPO Date | June 10, 2010 |
| Location | South Korea |
| Headquarters | 416 Yeongdong-daero |
| Employees | 466 |
| Sector | Healthcare |
| Industries | |
REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
Past 5 years
USD 7.87
USD 6.82
USD 89.76
StockViz Staff
February 5, 2025
Any question? Send us an email